Incyte Corporation Revenue per Employee (INCY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Incyte Corporation  (NASDAQ: INCY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Incyte's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 14% in the third quarter 2026, year on year to cumulative value of $6,011 million, Incyte's revenue per employee grew on a trailing twelve months basis to $ 2,113,486, this is below the company average.
Within the Healthcare sector Employees of 5 other companies have achieved higher revenue per employee. While Incyte's total ranking has deteriorated compared to the previous quarter from 108 to 143. Incyte has 2,844 employees.


What is Sales per Employee Ratio?







INCY Revenue per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Revenue Change 14 % 37.72 % 20.87 % 27.84 % 20.05 %
Sales per Employee (TTM) $ 2,113,486 2,046,248 1,885,028 1,807,750 1,692,372
INCY's Total Ranking # 143 # 108 # 78 # #
Seq. Revenue Change -6.98 % 31.54 % -15.54 % 10.31 % 12.38 %


Revenue per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 1
Healthcare Sector # 6
Overall Market # 143

Revenue per Employee Statistics
High Average Low
$ 1,885,028 $ 845,188 $ 134,372
(Mar 31 2026)   (June 30. 2014)



Financial Statements
Incyte's Revenue MRQ $ 1,557 Millions Visit INCY's Income Statement
Incyte's Revenues TTM $ 6,011 Millions Visit INCY's aggregate revenue growth
What are INCY's Sales? Visit INCY's Sales by Segment




Other Ratios
Incyte's Income per Employee
Employees in Medical Laboratories
Medical Laboratories Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
INCY's Revenue per Employee versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for INCY's Competitors
Revenue per Employee for INCY's Suppliers
Revenue per Employee for INCY's Customers

You may also want to know
INCY's Sales Growth Rates INCY's Pe Price to earnings ratio INCY's Receivables Turnover Ratio INCY's Stock Quote
INCY's Net Income Growth Rates INCY's Ps Price to Sales ratio INCY's Sales per Employee INCY's Asset Turnover Ratio
INCY's Net Margin INCY's Pb Price to Book ratio INCY's Financial Strength Ratios INCY's Dividend Payout Ratio
Date modified: 2026-10-30T16:59:18+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.